Twincretin drug Tirzepatide shows unmatched efficacy in weight loss and diabetes management

FHS
July 15, 2024
4:30 am

Tirzepatide, a novel twincretin drug, significantly improves weight loss and glycemic control in obese and type 2 diabetes patients, outperforming traditional treatments in clinical trials.

SPLICER shows promise in Alzheimer’s and other diseases

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce the formation of amyloid-beta

December 24, 2024

New framework aims to accelerate nanomedicine development

Nanomedicines save lives, but they don’t reach the market or the patient’s body fast enough. Researchers have now come up with a recipe to accelerate

February 28, 2025

Childhood diabetes rates surge globally

Researchers investigate global trends in childhood diabetes rates and different factors that contribute to its incidence.

December 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.